Fluidx Medical’s Embolic Demonstrates Novel Visibility Advantage
Fluidx Medical Reports Initial Research on First-of-its-Kind Embolic Agent with Intermediate Radiopacity
GPX Embolic Device Success in Challenging Tumor Case
Fluidx Medical’s Novel Embolic Device Demonstrates Repeated Success in Treating Complex Tumors
Fluidx Medical Technology Announces Series A Led by Multinational Strategic Investor
Novel Oncology Embolic Device financing supports prospective, clinical trials and market entry
Innovative Embolic Device Shows Promise for Interventional Oncology Drug Delivery
Fluidx Medical’s GPX Embolic Device Releases Initial Results for Oncology Drug Delivery
Fluidx Medical Technology’s Innovative Embolic Tumor Treating Device Highlighted in “BEST of GEST” Session at the Global Embolization Oncology Symposium Technologies (“GEST”) Conference
Fluidx Medical’s GPX™ Embolic Device Use for Tumor Treatments Chosen for “BEST of GEST” Embolization Program at the Annual GEST Meeting.
